Page 97 - NCCN Guidelines for Patients® | Non-Small Cell Lung Cancer

97 NCCN Guidelines for Patients®: Non-Small Cell Lung Cancer
Version 1.2013
Index
Anxiety 78, 79
Biopsy 18, 19, 22–25
Cancer staging 32–34
Caregivers 82
Chemotherapy 49, 50, 66–71
Clinical trials 71, 73
Complementary and alternative medicine 52
Depression 78
Gene changes 9, 38, 67, 68
Imaging tests 16, 36
Lung cancer 7–11
Lymph nodes 10, 24, 32, 45
Maintenance treatment 69
Member Institutions 95
Molecular tests 38
Multiple primary tumors 64
National Comprehensive Cancer Network 4, 92
Nodules 12, 16–19
Panel Members 93
Performance status 67, 68, 70
Pleura 8, 9, 25, 30, 33, 56, 66
Pulmonary function tests 36
Radiation therapy 47, 48, 57
Risk factors 13
Screening 4, 17, 20, 72
Side effects 45, 46, 48, 49, 51, 66, 77, 79
Sleep 48, 78
Surgery 43–46
Survivorship 72, 79, 83
Supportive care 64, 65, 67, 70, 71
Targeted therapy 42, 50, 51, 67
Treatment options 56–73
Treatment planning 76, 80, 81